Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 28, 2015; 21(16): 4933-4945
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4933
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4933
Variables | All patients (n = 105) | LL group (n = 55) | HL group (n = 34) | HH group (n = 16) | P value |
Age (yr) | 62 (57-68) | 62 (59-66) | 64 (56-70) | 63 (56-70) | 0.962 |
Sex, male/female | 90/15 | 48/7 | 29/5 | 13/3 | 0.829 |
Body mass index (kg/m2) | 23.7 ± 3.1 | 24.0 ± 2.6 | 23.5 ± 3.3 | 23.1 ± 4.3 | 0.691 |
Open/pure lap/lap-assisted | 83/8/14 | 43/6/6 | 29/1/4 | 11/1/4 | 0.390 |
Hr | |||||
0/S/1/2/3 | 50/25/14/14/2 | 34/13/6/2/0 | 14/10/4/4/2 | 2/2/4/8/0 | < 0.001 |
Preoperative laboratory values | |||||
Aspartate transaminase (U/L) | 31 (22-46) | 31 (22-41) | 30 (25-48) | 43 (24-62) | 0.153 |
Alanine transaminase (U/L) | 29 (20-39) | 32 (17-42) | 27 (21-42) | 27 (19-52) | 0.978 |
Platelets (× 104/μL) | 16.6 ± 13.3 | 16.4 ± 12.7 | 16.2 ± 16.2 | 18.0 ± 8.6 | 0.168 |
Serum ALB (g/dL) | 3.95 ± 0.46 | 3.99 ± 0.46 | 3.87 ± 0.43 | 3.98 ± 0.53 | 0.334 |
PT (%) | 93.3 ± 12.2 | 95.5 ± 11.1 | 90.3 ± 14.1 | 92.2 ± 10.6 | 0.062 |
Serum TBIL (mg/dL) | 0.79 ± 0.44 | 0.80 ± 0.45 | 0.85 ± 0.49 | 0.65 ± 0.24 | 0.681 |
ICGR15 | 9.6 (5.7-14.9) | 9.4 (5.9-14.0) | 12.5 (5.7-22.5) | 8.5 (5.0-14.6) | 0.334 |
AFP (ng/mL) | 24.2 (3.8-165.0) | 5.2 (2.4-31.1) | 45.0 (5.1-246.5) | 1950 (753.5-2827.0) | < 0.001 |
DCP (mAU/mL) | 38 (20-364) | 22 (15-28) | 399 (90-1,667) | 4460 (223-34373) | < 0.001 |
Intraoperative data | |||||
Blood loss (mL) | 400 (130-660) | 360 (110-560) | 435 (100-1,040) | 880 (130-1330) | 0.042 |
Surgical duration (min) | 332 (243-411) | 313 (236-370) | 361 (243-450) | 432 (270-604) | 0.020 |
Blood transfusion | |||||
RCC: yes/no (%) | 21/84 (20.0%) | 4/51 (7.2%) | 10/24 (29.4%) | 7/9 (43.8%) | 0.001 |
Pathological results | |||||
Tumor size (cm) | 4.27 ± 3.21 | 3.26 ± 2.56 | 4.97 ± 2.71 | 6.24 ± 4.77 | < 0.001 |
Multiple tumors: yes/no (%) | 39/66 (37.1%) | 19/36 (34.5%) | 15/19 (44.1%) | 5/11 (31.3%) | 0.575 |
Vascular invasion: yes/no (%) | 34/71 (32.4%) | 10/45 (18.2%) | 14/20 (41.1%) | 10/6 (62.5%) | 0.002 |
Remnant liver: NL/CH/LC | 13/47/41 | 6/23/26 | 3/17/14 | 4/7/5 | 0.464 |
Histological tumor differentiation | |||||
Well/moderately/poorly | 14/63/28 | 11/35/9 | 3/18/13 | 0/10/6 | 0.048 |
Recurrence within 2 yr after liver resection | |||||
Yes/no (%) | 50/55 (47.6%) |
- Citation: Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(16): 4933-4945
- URL: https://www.wjgnet.com/1007-9327/full/v21/i16/4933.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i16.4933